Daniel Alberto Madrid González

Daniel Alberto Madrid González

Auto-generated profile, based on publicly available information

Daniel Alberto Madrid González

Universidad del Valle de Cuernavaca

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2025 in SAGA: Revista Científica Multidisciplinar
Verified
Journal Article
Open access
PDF file
JEJorge Angel Velasco Espinal
Jorge Angel Velasco Espinal
JGJorge Arizmendi García
Jorge Arizmendi García
HJHannia Martínez Jaimes
Hannia Martínez Jaimes
DGDaniel Alberto Madrid González
Daniel Alberto Madrid González
DJDulce Isabel Pérez Jardón
Dulce Isabel Pérez Jardón
AGAylin Martínez Gutiérrez
Aylin Martínez Gutiérrez
Este estudio analiza la prevalencia de sintomatología depresiva y las barreras de acceso al diagnóstico y tratamiento en una muestra de 1,400 personas adultas en México. Se aplicó un cuestionario virtual con preguntas de opción múltiple orientadas a detectar síntomas frecuentes de depresión, condiciones de salud, percepciones sobre la calidad de vida, estigmatización, y actitudes frente a la atención en salud mental. Los resultados indican que más del 50 % de los participantes ha experimentado tristeza persistente, pérdida de interés en actividades, alteraciones del sueño, pensamientos negativos o cambios en apetito. Sin embargo, solo el 22.7 % ha recibido un diagnóstico profesional y apenas el 9.1 % se encuentra en tratamiento actualmente. El 88 % considera que los servicios de salud mental son poco o moderadamente accesibles, y un 44.5 % ha sido testigo de estigmatización. La calidad de vida se percibe como regular o baja en más del 35 % de los casos, y el 42.7 % reportó que la depresión ha afectado su desempeño laboral o escolar. Las motivaciones principales para buscar atención incluyen la disponibilidad de servicios gratuitos y cercanos (42.7 %) y la recomendación de un profesional o familiar (20.9 %). Estos hallazgos permiten visibilizar el desfase entre la prevalencia de síntomas y el acceso a atención oportuna, y proporcionan evidencia útil para el diseño de intervenciones comunitarias y políticas públicas de salud mental.

1 March 2018 in Salud Pública de México
Verified
Journal Article
Open access
PDF file
ÁMÁngela Patricia Mora-González
Ángela Patricia Mora-González
DMDaniel Alberto Madrid-González
Daniel Alberto Madrid-González
Sofia Barragán-VázquezSofia Barragán-Vázquez
Sofia Barragán-Vázquez
El pasado 19 de septiembre de 2017 se registró un sismo, de magnitud de 7.1 grados Richter al sureste de Axochiapan, en Morelos. Lo anterior implicó un total de 74 fallecimientos, más 20 000 viviendas afectadas, así como la evacuación de 18 hospitales y 281 unidades de primer nivel de atención médica. Dos meses después, las acciones de atención por parte del sector salud a la población damnificada continúan. Esta pobla¬ción pasó de 3 173 personas pernoctantes, concentradas en 49 refugios en el pico máximo, a un total de 1 512 personas, en 23 refugios temporales. Se implementaron acciones en materia de salud pública, como protección a riesgos sanitarios, vigilancia epidemiológica, promoción a la salud, prevención de enfermedades, atención en salud y rehabilitación. El presente artículo describe las acciones realizadas durante y después del sismo por parte del sector salud, con el fin de proveer un panorama en materia de salud pública basado en evidencia para situaciones de emergencia.

19 November 2025 in IECCMEXICO
Verified
Journal Article
Closed access
RGRicardo Daniel Corona Gonzalez
Ricardo Daniel Corona Gonzalez
RRRuddy Solange García Rosero
Ruddy Solange García Rosero
PHPablo Isaac Vera Heredia
Pablo Isaac Vera Heredia
VVVíctor Junior Godínez Vázquez
Víctor Junior Godínez Vázquez
JEJorge Angel Velasco Espinal
Jorge Angel Velasco Espinal
DRDiana Flores Rios
Diana Flores Rios
Digital health interventions are transforming chronic disease management by enabling more proactive, accessible, and patient-centered models of care. This review synthesizes evidence from remote monitoring systems, mobile health applications, telehealth services, patient portals, and digital behavioral interventions to examine how these tools influence patient behaviors, clinical pathways, and health system performance. Across the included studies, remote monitoring technologies consistently support earlier detection of symptom deterioration and facilitate timely clinical interventions, helping patients maintain stability in conditions such as heart failure, COPD, diabetes, and chronic pain. Mobile health applications and self-management platforms improve adherence, reinforce daily routines, and enhance patient autonomy through structured guidance, behavioral prompting, and real-time feedback. Telehealth services strengthen communication, reduce geographic barriers, and offer continuity of care for vulnerable and rural populations, while patient portals increase preparedness for consultations and improve therapeutic engagement. Evidence also shows that digital tools enhance the emotional dimension of care by providing reassurance and a sense of ongoing support. However, the benefits of digital health depend heavily on usability, digital literacy, personalization, and sustained engagement; challenges in these areas frequently contribute to fluctuating participation or dropout. At the system level, the impact of digital health is mediated by organizational readiness, interoperability, and workflow integration, underscoring that technology must be embedded within coherent institutional strategies. For countries such as Mexico, Colombia, and Ecuador, digital health holds considerable promise but requires targeted investments in infrastructure, training, and equity-oriented implementation. Overall, digital health offers a compelling pathway for advancing long-term chronic disease care when aligned with human-centered design and system-level preparedness.

8 October 2025 in International Science Journal
Verified
Journal Article
Closed access
ÁAÁngela Patricia López Alvarado
Ángela Patricia López Alvarado
JAJosé Enrique González Araujo
José Enrique González Araujo
SMSTEPHANIE Mora
STEPHANIE Mora
ARAlan Chavez Rubio
Alan Chavez Rubio
JEJorge Angel Velasco Espinal
Jorge Angel Velasco Espinal
JLJorge Luis Jimenez Loza
Jorge Luis Jimenez Loza
Advances in genomics and immunology have redefined the understanding of immune regulation, disease susceptibility and therapeutic response. This review synthesizes evidence across multiple biological scales—including germline variation, somatic mutations, epigenomic architecture and single-cell immune heterogeneity—to elucidate how genomic mechanisms shape immune function in health and disease. Emphasis is placed on the translational relevance of these mechanisms, particularly in the context of cancer immunotherapy, autoimmune risk stratification and emerging engineered-immunity platforms such as CRISPR-based editing and CAR T-cell therapies. The analysis also highlights the persistent underrepresentation of populations from Mexico, Colombia and Ecuador in genomic datasets, underscoring the need for inclusive precision-medicine strategies. By integrating mechanistic, technological and clinical dimensions, this review outlines the conceptual foundations of immunogenomics and identifies the opportunities and challenges that will shape its evolution as a global, population-relevant discipline.

5 November 2025 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
ARAugusto Cam Rojas
Augusto Cam Rojas
DGDaniel Alberto Madrid González
Daniel Alberto Madrid González
AEAbdiel Arias Estrada
Abdiel Arias Estrada
PAPerla Gabriela Hershberger Arrechea
Perla Gabriela Hershberger Arrechea
MAMaria Fernanda Venero Acurio
Maria Fernanda Venero Acurio
BHBerenice Lira Hernández
Berenice Lira Hernández
Endometriosis is increasingly recognized as a systemic inflammatory disease rather than a localized gynecological disorder. This review integrates recent molecular and clinical evidence demonstrating how chronic inflammation, oxidative stress, and extracellular vesicle (EV) signaling interact to shape both local and systemic pathophysiology. Elevated cytokines such as IL-1β, IL-6, TNF-α, IL-8, MCP-1, and VEGF sustain angiogenesis, immune activation, and lesion persistence, while diminished IL-10 impairs immunoregulation. Concurrently, oxidative stress arising from peritoneal iron overload and mitochondrial dysfunction amplifies inflammatory signaling through NF-κB and TGF-β/SMAD pathways, promoting fibrosis, apoptosis resistance, and nociceptor sensitization. Recent discoveries highlight EVs as mediators of systemic communication, transferring microRNAs and proteins that modulate immune, endothelial, and neural targets, thereby linking pelvic inflammation to cardiovascular, metabolic, and autoimmune comorbidities. Evidence from multiple studies indicates that endometriosis confers elevated risks of hypertension, dyslipidemia, autoimmune disorders, and mood disturbances—hallmarks of systemic immune and vascular dysregulation. Furthermore, chronic oxidative and inflammatory exposure fosters genomic instability, explaining the observed association with ovarian clear-cell and endometrioid carcinomas. Recognizing endometriosis as a multisystemic disorder supports the development of integrative diagnostic and therapeutic strategies, including cytokine and exosomal biomarker panels and targeted anti-inflammatory, antioxidant, and anti-angiogenic treatments. Contributions from Mexico, Colombia, and Ecuador emphasize the need for regionally inclusive research and precision-medicine approaches. Endometriosis thus emerges as a model of systemic inflammation, exemplifying how immune, oxidative, and endocrine networks converge to produce both reproductive and extra-pelvic disease manifestations.

30 June 2026 in International Science Journal
Verified
Journal Article
Open access
PDF file
DADayanna Estefania Fernández Astudillo
Dayanna Estefania Fernández Astudillo
CHCristian David Castro Hernandez
Cristian David Castro Hernandez
MSMaría Alejandra Galindo Van Strahlen
María Alejandra Galindo Van Strahlen
SRSebastián Prieto Rueda
Sebastián Prieto Rueda
EPElsa Noralma Lucas Parrales
Elsa Noralma Lucas Parrales
DGDaniel Alberto Madrid González
Daniel Alberto Madrid González
Pharmacogenomic variability represents an increasingly relevant determinant of therapeutic response, drug toxicity, and treatment failure in emergency and internal medicine. This study analyzed the clinical applicability of actionable gene–drug interactions associated with acute pharmacological decision-making, severe adverse drug reactions, and the potential integration of genomic information into emergency-care workflows. A structured integrative review based on the Scientific Method was conducted using pharmacogenomic guidelines, implementation studies, regulatory resources, and clinically oriented evidence. Particular attention was given to associations involving CYP2D6, CYP2C19, CYP2C9, VKORC1, G6PD, RYR1, CACNA1S, HLA-B, SLCO1B1, TPMT, and NUDT15. The evidence demonstrated that pharmacogenomic-guided prescribing can be associated with measurable differences in medication safety. In the PREPARE study, clinically relevant adverse drug reactions occurred in 21.0% of patients managed with genotype-guided treatment compared with 27.7% receiving standard care. In an emergency department cohort, actionable pharmacogenomic variants were identified in 99% of patients, while clinically relevant gene–drug pairs were detected in 53%. The analyzed interactions were mainly associated with altered drug metabolism, modified pharmacological sensitivity, severe genetically mediated adverse reactions, and delayed toxicities capable of producing acute-care presentations. Pharmacogenomic information showed potential utility for medication selection, dose modification, drug avoidance, risk stratification, and prevention of recurrent adverse events. Nevertheless, its clinical value depends on integration with renal and hepatic function, comorbidities, drug interactions, disease severity, and conventional emergency assessment. Preemptive testing integrated into electronic health records appears to be one of the most feasible models for emergency implementation because it allows actionable results to be available before time-sensitive treatment decisions. Pharmacogenomics may therefore contribute to a more preventive, individualized, and precise approach to medication safety in acute care, although prospective emergency-specific studies, interoperable systems, population-diverse validation, and equitable access remain necessary for broader implementation.